Clinical Trials

Showing trials with last updates posted in 2024.

NCT04691804 | ACTIVE_NOT_RECRUITING | PHASE3
496 participants

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-31
Start Date:
2021-03-18
Completion:
2026-12-31
Conditions
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Interventions
  • DRUG
No Results Yet
NCT03535727 | COMPLETED | PHASE1/PHASE2
48 participants

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-31
Start Date:
2018-06-21
Completion:
2022-10-03
Conditions
  • Adenocarcinoma
  • Pancreatic Neoplasms
  • Neoplasm, Glandular
  • Neoplasms
  • Neoplasms Pancreatic
  • Digestive System Neoplasm
  • Endocrine Gland Neoplasms
  • Digestive System Disease
  • Pancreatic Diseases
  • Endocrine System Diseases
Interventions
  • DRUG
NCT03493542 | COMPLETED | PHASE3
766 participants

A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-31
Start Date:
2018-08-31
Completion:
2023-10-30
Conditions
  • Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Interventions
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page